Original Investigation

Sex Differences in Mortality and Receipt of Kidney Replacement Therapy Among Adults With Stage 5 Chronic Kidney Disease

JAMA Internal Medicine 10.1001/jamainternmed.2025.5979

November 17, 2025 at 11:00 AM EST

Read the full article

Does the female survival advantage observed in the general population persist among adults with stage 5 chronic kidney disease (CKD)?In this cohort study of 7506 adults with incident stage 5 CKD in Alberta, Canada, female individuals were older at disease onset than male individuals. In analyses stratified by age and comorbidities, female individuals younger than 55 years were less likely to survive or receive a kidney transplant than male individuals; female individuals older than 65 years had similar survival but were less likely to receive dialysis.Female individuals may no longer outlive male individuals after developing stage 5 CKD, and their worse outcomes at younger ages warrant further investigation.

Corresponding Author: Ping Liu, PhD, Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, 3230 Hospital Dr NW, Calgary, AB T2N 4Z6, Canada (ping.liu1@ucalgary.ca).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2025.5979?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111725

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks